ConductScience.org, home

Paper40409258

Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.

Sirenko M and 34 others. Cell Stem Cell, 2025. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia. Papers, record 40409258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40409258

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia.
PubMed
Journal
Cell Stem Cell
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
4.82, provisional
iCite
Revised in PubMed
2026-09-09
PubMed

Authors35

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sirenko MMaria
2Lee SSoobeom
3Sun ZZhengxi
4Chaligne RRonan
5Loghavi SSanam
6Asimomitis GGeorgios
7Brierley CKCharlotte K
8Bernard EElsa
9Cai SFSheng F
10Myers RMRobert M
11Nadorp BBettina
12Sango JJunya
13Lallo MMorgan
14Levine MFMax F
15Domenico DDylan
16Arango Ossa JEJuan E
17Medina-Martinez JSJuan S
18Menghrajani KKamal
19Lasry AAudrey
20Mims ASAlice S

Source PubMed

See all 35 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Leukemia, Myeloid, AcuteMajor topic
Isocitrate DehydrogenaseMajor topic
MutationMajor topic
Humans
Nucleophosmin
Clone Cells
Animals

Source PubMed

Download CSV of topics

Grants23

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 CA284595NCI NIH HHSUnited StatesR01CA284595PubMed and NIHNIH RePORTER
K08 CA241371NCI NIH HHSUnited StatesK08CA241371PubMed and NIHNIH RePORTER
R01 HL128239NHLBI NIH HHSUnited StatesR01HL128239PubMed and NIHNIH RePORTER
R01 CA266212NCI NIH HHSUnited StatesR01CA266212PubMedNIH RePORTER
P30 CA008748NCI NIH HHSUnited StatesP30CA008748PubMedNIH RePORTER
R01 HL157387NHLBI NIH HHSUnited StatesR01HL157387PubMed and NIHNIH RePORTER
R01 HL159175NHLBI NIH HHSUnited StatesR01HL159175PubMed and NIHNIH RePORTER
R01 CA271418NCI NIH HHSUnited StatesR01CA271418PubMed and NIHNIH RePORTER
P30 CA016058NCI NIH HHSUnited StatesP30CA016058PubMedNIH RePORTER
T32 GM007739NIGMS NIH HHSUnited StatesT32GM007739PubMed and NIHNIH RePORTER
F31 CA254130NCI NIH HHSUnited StatesF31CA254130PubMed and NIHNIH RePORTER
P01 CA229086NCI NIH HHSUnited StatesP01CA229086PubMedNIH RePORTER
R01 CA298153NCI NIH HHSUnited StatesR01CA298153PubMedNIH RePORTER
R01 CA228135NCI NIH HHSUnited StatesR01CA228135PubMed and NIHNIH RePORTER
R01 CA283574NCI NIH HHSUnited StatesR01CA283574PubMed and NIHNIH RePORTER
P50 CA254838NCI NIH HHSUnited StatesP50CA254838PubMed and NIHNIH RePORTER
R01 CA260711NCI NIH HHSUnited StatesR01CA260711PubMed and NIHNIH RePORTER
R01 LM013879NLM NIH HHSUnited StatesR01LM013879PubMed and NIHNIH RePORTER
R01 CA242020NCI NIH HHSUnited StatesR01CA242020PubMed and NIHNIH RePORTER
U54 DK126108NIDDK NIH HHSUnited StatesU54DK126108PubMedNIH RePORTER

See all 23 grantsDownload CSV of grants

References93

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134427990Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score matching analysis.Cancer Med2021https://conductscience.org/library/papers/34427990PubMed
227903985The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.Oncotarget2017https://conductscience.org/library/papers/27903985PubMed
335273342In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.Leukemia2022https://conductscience.org/library/papers/35273342PubMed
424442143The ID proteins: master regulators of cancer stem cells and tumour aggressiveness.Nat Rev Cancer2014https://conductscience.org/library/papers/24442143PubMed
525426837Age-related clonal hematopoiesis associated with adverse outcomes.N Engl J Med2014https://conductscience.org/library/papers/25426837PubMed
631004019Clonal hematopoiesis and risk of acute myeloid leukemia.Haematologica2019https://conductscience.org/library/papers/31004019PubMed
729898899Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.Genome Res2018https://conductscience.org/library/papers/29898899PubMed
831597962Decoding human fetal liver haematopoiesis.Nature2019https://conductscience.org/library/papers/31597962PubMed
931841594Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.Blood2020https://conductscience.org/library/papers/31841594PubMed
1031270458Somatic mutations and cell identity linked by Genotyping of Transcriptomes.Nature2019https://conductscience.org/library/papers/31270458PubMed
1135924979The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation.Cancer Discov2022https://conductscience.org/library/papers/35924979PubMed
1228280273A pharmacogenomic approach validates AG-221 as an effective and on-target therapy in IDH2 mutant AML.Leukemia2017https://conductscience.org/library/papers/28280273PubMed
1328803919Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.Cell Stem Cell2017https://conductscience.org/library/papers/28803919PubMed
1431160568A comprehensive single cell transcriptional landscape of human hematopoietic progenitors.Nat Commun2019https://conductscience.org/library/papers/31160568PubMed
1537098346Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemia.Cell Stem Cell2023https://conductscience.org/library/papers/37098346PubMed
1630540953The Molecular Signature of Megakaryocyte-Erythroid Progenitors Reveals a Role for the Cell Cycle in Fate Specification.Cell Rep2018https://conductscience.org/library/papers/30540953PubMed
1739478230RAS-mutant leukaemia stem cells drive clinical resistance to venetoclax.Nature2024https://conductscience.org/library/papers/39478230PubMed
1824440599Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance.Cell Stem Cell2014https://conductscience.org/library/papers/24440599PubMed
1932380538Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML.Blood Adv2020https://conductscience.org/library/papers/32380538PubMed
2029262330Hepatic Leukemia Factor Maintains Quiescence of Hematopoietic Stem Cells and Protects the Stem Cell Pool during Regeneration.Cell Rep2017https://conductscience.org/library/papers/29262330PubMed

See all 93 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42814135Very Long Chain Fatty Acid Synthesis is a Targetable Dependency in RAS Pathway Mutant Leukemia.Blood Cancer Discov2026https://conductscience.org/library/papers/42814135PubMed
42745000Type 1 interferon perturbates clonal competition by reshaping human blood development.Nat Genet2026https://conductscience.org/library/papers/42745000PubMed
42711452A single-cell lens into the co-evolution of genotypes and phenotypes in cancer.Nat Rev Cancer2026https://conductscience.org/library/papers/42711452PubMed
42697881Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity.Nat Commun2026https://conductscience.org/library/papers/42697881PubMed
42642621Ivosidenib monotherapy in IDH1 mutated myelodysplastic neoplasm/syndrome.Leukemia2026https://conductscience.org/library/papers/42642621PubMed
42402603TCA-controlled histone succinylation identifies IDH3B as a prognostic and therapeutic target in AML.Clin Epigenetics2026https://conductscience.org/library/papers/42402603PubMed
42380141Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers.Blood Cancer J2026https://conductscience.org/library/papers/42380141PubMed
42367953Accurate detection of tumor clonality and ongoing expansion mode from genomic data.bioRxiv2026https://conductscience.org/library/papers/42367953PubMed
42101375Single-cell long-read genotyping of transcripts reveals discrete mechanisms of clonal evolution in post-MPN AML.Blood Adv2026https://conductscience.org/library/papers/42101375PubMed
42073528The Spectrum of Venetoclax-Based Treatments in Acute Myeloid Leukemia.Cancers (Basel)2026https://conductscience.org/library/papers/42073528PubMed
42007444APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications.Hemasphere2026https://conductscience.org/library/papers/42007444PubMed
41936394Rare Gain-of-Function Variants in IDH1 and IDH2 Confer Increased Risk of Immune-Mediated Rheumatic Diseases.ACR Open Rheumatol2026https://conductscience.org/library/papers/41936394PubMed
41860384IDH1- and IDH2-mutated myeloid neoplasms: mutational pattern, clonal hierarchy, and the role in AML transformation.Blood Adv2026https://conductscience.org/library/papers/41860384PubMed
41814014Immunophenotypic changes following menin inhibition in acute myeloid leukemia.Leukemia2026https://conductscience.org/library/papers/41814014PubMed
41703030Reframing-renaming(?)-myelodysplastic syndromes/neoplasms and clonal hematopoiesis of indeterminate potential.Leukemia2026https://conductscience.org/library/papers/41703030PubMed
41460204MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response.Clin Cancer Res2026https://conductscience.org/library/papers/41460204PubMed
41258574Epigenetic reprogramming as the nexus of cancer stemness and therapy resistance: implications for biomarker discovery.Discov Oncol2025https://conductscience.org/library/papers/41258574PubMed
41046303Elucidating the risk factors and oncogene drivers of acute myeloid leukemia.Hum Cell2025https://conductscience.org/library/papers/41046303PubMed

Download CSV of cited by

Genes6

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
HLA-C3107PubTator's text mininghttps://conductscience.org/library/genes/3107NCBI Gene
IDH13417PubTator's text mininghttps://conductscience.org/library/genes/3417NCBI Gene
IDH23418PubTator's text mininghttps://conductscience.org/library/genes/3418NCBI Gene
NPM14869PubTator's text mininghttps://conductscience.org/library/genes/4869NCBI Gene
NRAS4893PubTator's text mininghttps://conductscience.org/library/genes/4893NCBI Gene
SRSF26427PubTator's text mininghttps://conductscience.org/library/genes/6427NCBI Gene

Download CSV of genes

Data1

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccession
GEOGSE230559

Source GEO

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40409258

GET https://conductscience.org/api/papers/v1/40409258/authors?page=2